Compare GMED & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GMED | FMS |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | United States | Germany |
| Employees | N/A | 108165 |
| Industry | Medical/Dental Instruments | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 11.6B |
| IPO Year | 2012 | N/A |
| Metric | GMED | FMS |
|---|---|---|
| Price | $79.14 | $23.50 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 14 | 2 |
| Target Price | ★ $100.42 | $30.00 |
| AVG Volume (30 Days) | ★ 1.7M | 636.2K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | ★ 422.67 | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $2,938,931,000.00 | N/A |
| Revenue This Year | $11.13 | N/A |
| Revenue Next Year | $6.28 | $3.83 |
| P/E Ratio | $88.03 | ★ $15.62 |
| Revenue Growth | ★ 16.65 | N/A |
| 52 Week Low | $51.79 | $20.02 |
| 52 Week High | $101.40 | $28.87 |
| Indicator | GMED | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 62.07 |
| Support Level | $77.41 | $22.50 |
| Resistance Level | $87.19 | $23.89 |
| Average True Range (ATR) | 2.39 | 0.33 |
| MACD | 0.07 | 0.22 |
| Stochastic Oscillator | 48.12 | 85.27 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.